Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells
Crossref DOI link: https://doi.org/10.1007/s10495-015-1137-x
Published Online: 2015-05-22
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Yan
Hurren, Rose
MacLean, Neil
Gronda, Marcela
Jitkova, Yulia
Sukhai, Mahadeo A.
Minden, Mark D.
Schimmer, Aaron D.
Funding for this research was provided by:
Canadian Stem Cell Network
Text and Data Mining valid from 2015-05-22